Vernalis plc (NASDAQ:VNLPY) has earned a consensus broker rating score of 3.00 (Hold) from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating.

Zacks has also assigned Vernalis plc an industry rank of 159 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research raised Vernalis plc from a “sell” rating to a “buy” rating and set a $0.75 price target on the stock in a report on Wednesday, September 20th.

Shares of Vernalis plc (VNLPY) opened at 0.51 on Friday. The firm’s market cap is $134.24 million. Vernalis plc has a 12-month low of $0.30 and a 12-month high of $0.95. The company has a 50 day moving average price of $0.54 and a 200-day moving average price of $0.57.

TRADEMARK VIOLATION WARNING: “Zacks: Vernalis plc (VNLPY) Given Consensus Rating of “Hold” by Brokerages” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at

About Vernalis plc

Vernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders.

Get a free copy of the Zacks research report on Vernalis plc (VNLPY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vernalis plc and related companies with's FREE daily email newsletter.